{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:33:19Z","timestamp":1793043199455,"version":"4.5.0"},"reference-count":275,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.addr.2022.114445","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T11:18:55Z","timestamp":1657365535000},"page":"114445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":266,"special_numbering":"C","title":["Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment"],"prefix":"10.1016","volume":"188","author":[{"given":"Quan","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiao","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbing","family":"Sui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.addr.2022.114445_b0005","first-page":"209","article-title":"GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.addr.2022.114445_b0010","first-page":"37","article-title":"Prevention and Treatment of Colorectal Cancer by Natural Agents From Mother Nature","volume":"9","author":"Aggarwal","year":"2013","journal-title":"Curr. Colorectal Cancer Rep."},{"key":"10.1016\/j.addr.2022.114445_b0015","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1752-4571.2008.00063.x","article-title":"Cancer research meets evolutionary biology","volume":"2","author":"Pepper","year":"2009","journal-title":"Evol. Appl."},{"key":"10.1016\/j.addr.2022.114445_b0020","doi-asserted-by":"crossref","unstructured":"E. Yague, A. Arance, L. Kubitza, M. O'Hare, P. Jat, C.M. Ogilvie, I.R. Hart, C.F. Higgins, S. Raguz, Ability to acquire drug resistance arises early during the tumorigenesis process, Cancer Res. 67 (2007) 1130-1137.","DOI":"10.1158\/0008-5472.CAN-06-2574"},{"key":"10.1016\/j.addr.2022.114445_b0025","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12951-021-00934-0","article-title":"Novel CD44-targeting and pH\/redox-dual-stimuli-responsive core-shell nanoparticles loading triptolide combats breast cancer growth and lung metastasis","volume":"19","author":"Shi","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.addr.2022.114445_b0030","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1016\/j.apsb.2020.05.011","article-title":"Injectable thermo-responsive nano-hydrogel loading triptolide for the anti-breast cancer enhancement via localized treatment based on \u201ctwo strikes\u201d effects","volume":"10","author":"Luo","year":"2020","journal-title":"Acta Pharmaceutica Sinica. B"},{"key":"10.1016\/j.addr.2022.114445_b0035","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.7150\/thno.42260","article-title":"Redox-sensitive carrier-free nanoparticles self-assembled by disulfide-linked paclitaxel-tetramethylpyrazine conjugate for combination cancer chemotherapy","volume":"11","author":"Zou","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2022.114445_b0040","doi-asserted-by":"crossref","first-page":"D1324","DOI":"10.1093\/nar\/gkab913","article-title":"NPCDR: natural product-based drug combination and its disease-specific molecular regulation","volume":"50","author":"Sun","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.addr.2022.114445_b0045","doi-asserted-by":"crossref","first-page":"4045","DOI":"10.1016\/j.apsb.2021.03.036","article-title":"Baicalin induces ferroptosis in bladder cancer cells by downregulating FTH1","volume":"11","author":"Kong","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.addr.2022.114445_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109142","article-title":"Natural products for treating colorectal cancer: A mechanistic review","volume":"117","author":"Huang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2022.114445_b0055","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2019.04.004","article-title":"Honokiol for cancer therapeutics: A traditional medicine that can modulate multiple oncogenic targets","volume":"144","author":"Banik","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.addr.2022.114445_b0060","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1038\/aps.2016.81","article-title":"Honokiol inhibits EMT-mediated motility and migration of human non-small cell lung cancer cells in vitro by targeting c-FLIP","volume":"37","author":"Lv","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"issue":"9","key":"10.1016\/j.addr.2022.114445_b0065","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1080\/10408398.2016.1263597","article-title":"Resveratrol as an anti-cancer agent: A review","volume":"58","author":"Rauf","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"key":"10.1016\/j.addr.2022.114445_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41392-020-0149-3","article-title":"Erianin, a novel dibenzyl compound in Dendrobium extract, inhibits lung cancer cell growth and migration via calcium\/calmodulin-dependent ferroptosis","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.addr.2022.114445_b0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2021.102461","article-title":"pH\/ROS dual-sensitive and chondroitin sulfate wrapped poly (\u03b2-amino ester)-SA-PAPE copolymer nanoparticles for macrophage-targeted oral therapy for ulcerative colitis","volume":"39","author":"Xu","year":"2022","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"10.1016\/j.addr.2022.114445_b0080","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.med.53.082901.103929","article-title":"Mechanisms of cancer drug resistance","volume":"53","author":"Gottesman","year":"2002","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.addr.2022.114445_b0085","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/s41416-020-1025-1","article-title":"Broccoli extract increases drug-mediated cytotoxicity towards cancer stem cells of head and neck squamous cell carcinoma","volume":"123","author":"Elkashty","year":"2020","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2022.114445_b0090","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1038\/onc.2014.92","article-title":"Progranulin promotes Temozolomide resistance of glioblastoma by orchestrating DNA repair and tumor stemness","volume":"34","author":"Bandey","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.addr.2022.114445_b0095","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jconrel.2016.06.012","article-title":"Nanomedicine of synergistic drug combinations for cancer therapy - Strategies and perspectives","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2022.114445_b0100","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/acs.accounts.9b00148","article-title":"Combining Nanomedicine and Immunotherapy","volume":"52","author":"Shi","year":"2019","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.addr.2022.114445_b0105","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jcis.2016.12.025","article-title":"Enhanced chemotherapeutic efficacy of apigenin liposomes in colorectal cancer based on flavone-membrane interactions","volume":"491","author":"Banerjee","year":"2017","journal-title":"J. Colloid Interface Sci."},{"issue":"3","key":"10.1016\/j.addr.2022.114445_b0110","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1080\/17425247.2020.1727442","article-title":"Phytosterol-loaded CD44 receptor-targeted PEGylated nano-hybrid phyto-liposomes for synergistic chemotherapy","volume":"17","author":"Gautam","year":"2020","journal-title":"Expert Opin. Drug Deliv."},{"issue":"9","key":"10.1016\/j.addr.2022.114445_b0115","doi-asserted-by":"crossref","first-page":"7698","DOI":"10.1021\/nn402232g","article-title":"Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors","volume":"7","author":"Jang","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2022.114445_b0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.addr.2016.01.019","article-title":"Killing two birds or more with one stone","volume":"98","author":"Heo","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2022.114445_b0125","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.msec.2019.01.123","article-title":"Novel biosynthesized gold nanoparticles as anti-cancer agents against breast cancer: Synthesis, biological evaluation, molecular modelling studies","volume":"99","author":"Vemuri","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.addr.2022.114445_b0130","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41392-018-0019-4","article-title":"A nanomedicine approach enables co-delivery of cyclosporin A and gefitinib to potentiate the therapeutic efficacy in drug-resistant lung cancer","volume":"3","author":"Han","year":"2018","journal-title":"Signal Transduct. Target Ther."},{"key":"10.1016\/j.addr.2022.114445_b0135","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3389\/fphar.2018.01214","article-title":"Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2\/STAT3 Signaling Pathway","volume":"9","author":"Chen","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2018.10.032","article-title":"Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: Implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments","volume":"192","author":"Wan","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2022.114445_b0145","doi-asserted-by":"crossref","unstructured":"M. Zhang, C.T.t. Hagan, Y. Min, H. Foley, X. Tian, F. Yang, Y. Mi, K.M. Au, Y. Medik, K. Roche, K. Wagner, Z. Rodgers, A.Z. Wang, Nanoparticle co-delivery of wortmannin and cisplatin synergistically enhances chemoradiotherapy and reverses platinum resistance in ovarian cancer models, Biomaterials, 169 (2018) 1-10.","DOI":"10.1016\/j.biomaterials.2018.03.055"},{"key":"10.1016\/j.addr.2022.114445_b0150","doi-asserted-by":"crossref","unstructured":"I. Bijnsdorp, E. Giovannetti, G.J.M.i.m.b. Peters, Analysis of drug interactions, 731 (2011) 421-434.","DOI":"10.1007\/978-1-61779-080-5_34"},{"issue":"6","key":"10.1016\/j.addr.2022.114445_b0155","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00280-013-2151-8","article-title":"A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients","volume":"71","author":"Kanai","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0160","first-page":"1894","article-title":"Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer","volume":"7","author":"Sharma","year":"2001","journal-title":"Clin. Cancer Res."},{"issue":"11","key":"10.1016\/j.addr.2022.114445_b0165","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrclinonc.2014.153","article-title":"Clinical cancer research: the past, present and the future","volume":"11","author":"DeVita","year":"2014","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.addr.2022.114445_b0170","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrclinonc.2015.209","article-title":"Combination cancer immunotherapies tailored to the tumour microenvironment","volume":"13","author":"Smyth","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"12","key":"10.1016\/j.addr.2022.114445_b0175","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41568-020-0297-3","article-title":"Improving human cancer therapy through the evaluation of pet dogs","volume":"20","author":"LeBlanc","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"2","key":"10.1016\/j.addr.2022.114445_b0180","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/hep.23384","article-title":"Contemporary clinical research of traditional Chinese medicines for chronic hepatitis B in China: an analytical review","volume":"51","author":"Zhang","year":"2010","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.addr.2022.114445_b0185","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.molmed.2007.07.001","article-title":"From traditional Chinese medicine to rational cancer therapy","volume":"13","author":"Efferth","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"23","key":"10.1016\/j.addr.2022.114445_b0190","doi-asserted-by":"crossref","first-page":"38022","DOI":"10.18632\/oncotarget.16723","article-title":"Combination therapy in combating cancer","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.addr.2022.114445_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102144","article-title":"Apigenin enhances apoptosis induction by 5-fluorouracil through regulation of thymidylate synthase in colorectal cancer cells","volume":"47","author":"Yang","year":"2021","journal-title":"Redox Biol."},{"issue":"4","key":"10.1016\/j.addr.2022.114445_b0200","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/1878-0261.12645","article-title":"Overcoming acquired resistance of EGFR-mutant NSCLC cells to the third generation EGFR inhibitor, osimertinib, with the natural product honokiol","volume":"14","author":"Zang","year":"2020","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.addr.2022.114445_b0205","doi-asserted-by":"crossref","first-page":"9453","DOI":"10.2147\/IJN.S224579","article-title":"Co-Delivery of Curcumin and Paclitaxel by \u201cCore-Shell\u201d Targeting Amphiphilic Copolymer to Reverse Resistance in the Treatment of Ovarian Cancer","volume":"14","author":"Zhao","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2022.114445_b0210","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1568009613666131113100634","article-title":"Suppression of NF-kappaB signaling and P-glycoprotein function by gambogic acid synergistically potentiates adriamycin -induced apoptosis in lung cancer","volume":"14","author":"Wang","year":"2014","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.addr.2022.114445_b0215","first-page":"1695","article-title":"Sequencedependent effect of sorafenib in combination with natural phenolic compounds on hepatic cancer cells and the possible mechanism of action","volume":"42","author":"Bahman","year":"2018","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.addr.2022.114445_b0220","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.canlet.2018.05.006","article-title":"Fucoidan upregulates TLR4\/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells","volume":"432","author":"Hsu","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2022.114445_b0225","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1021\/acs.molpharmaceut.0c00138","article-title":"Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate\/d-alpha-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles","volume":"17","author":"Liu","year":"2020","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.addr.2022.114445_b0230","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/10717544.2020.1785581","article-title":"Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect","volume":"27","author":"Xu","year":"2020","journal-title":"Drug Deliv."},{"issue":"18","key":"10.1016\/j.addr.2022.114445_b0235","doi-asserted-by":"crossref","first-page":"5029","DOI":"10.1039\/D0BM00840K","article-title":"Multi pH-sensitive polymer\u2013drug conjugate mixed micelles for efficient co-delivery of doxorubicin and curcumin to synergistically suppress tumor metastasis","volume":"8","author":"Zhou","year":"2020","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.addr.2022.114445_b0240","first-page":"1","article-title":"Insights on the Multifunctional Activities of Magnolol","volume":"2019","author":"Zhang","year":"2019","journal-title":"Biomed. Res. Int."},{"issue":"1","key":"10.1016\/j.addr.2022.114445_b0245","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s13402-020-00557-x","article-title":"Synergistic killing effect of paclitaxel and honokiol in non-small cell lung cancer cells through paraptosis induction","volume":"44","author":"Li","year":"2021","journal-title":"Cell Oncol. (Dordr.)"},{"key":"10.1016\/j.addr.2022.114445_b0250","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1021\/acs.chemrestox.6b00451","article-title":"Honokiol Inhibits DNA Polymerases beta and lambda and Increases Bleomycin Sensitivity of Human Cancer Cells","volume":"30","author":"Gowda","year":"2017","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.addr.2022.114445_b0255","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3892\/or.2015.4091","article-title":"Honokiol exhibits enhanced antitumor effects with chloroquine by inducing cell death and inhibiting autophagy in human non-small cell lung cancer cells","volume":"34","author":"Lv","year":"2015","journal-title":"Oncol. Rep."},{"issue":"17","key":"10.1016\/j.addr.2022.114445_b0260","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.2174\/1871520620666201020160348","article-title":"Resveratrol as an Enhancer of Apoptosis in Cancer: A Mechanistic Review","volume":"21","author":"Ashrafizadeh","year":"2021","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.addr.2022.114445_b0265","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3892\/ijo.2015.3124","article-title":"Resveratrol enhanced anticancer effects of cisplatin on non-small cell lung cancer cell lines by inducing mitochondrial dysfunction and cell apoptosis","volume":"47","author":"Ma","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.addr.2022.114445_b0270","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.lfs.2018.07.035","article-title":"Resveratrol sensitizes lung cancer cell to TRAIL by p53 independent and suppression of Akt\/NF-kappaB signaling","volume":"208","author":"Rasheduzzaman","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2022.114445_b0275","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/bjc.2013.752","article-title":"Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-kappaB and MAPK\/HO-1 signalling","volume":"110","author":"Wang","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.addr.2022.114445_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173486","article-title":"Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer","volume":"888","author":"Hatami","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0285","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/jcp.22719","article-title":"Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells","volume":"227","author":"Yu","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.addr.2022.114445_b0290","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104463","article-title":"Pharmacological properties and derivatives of shikonin-A review in recent years","volume":"149","author":"Guo","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.addr.2022.114445_b0295","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.lfs.2018.05.012","article-title":"Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2\/stat3\/cyclinD1 signal pathway","volume":"204","author":"Tang","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.addr.2022.114445_b0300","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.3892\/ol.2017.6702","article-title":"Shikonin enhances Adriamycin antitumor effects by inhibiting efflux pumps in A549 cells","volume":"14","author":"Liu","year":"2017","journal-title":"Oncol. Lett."},{"issue":"7","key":"10.1016\/j.addr.2022.114445_b0305","doi-asserted-by":"crossref","first-page":"8555","DOI":"10.1007\/s13277-015-4719-x","article-title":"The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells","volume":"37","author":"Zhou","year":"2016","journal-title":"Tumour Biol."},{"issue":"2","key":"10.1016\/j.addr.2022.114445_b0310","first-page":"2728","volume":"20","author":"Shanmugam","year":"2015","journal-title":"The multifaceted role of curcumin in cancer prevention and treatment"},{"issue":"3","key":"10.1016\/j.addr.2022.114445_b0315","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3727\/096504013X13832473330032","article-title":"Curcumin lowers erlotinib resistance in non-small cell lung carcinoma cells with mutated EGF receptor","volume":"21","author":"Li","year":"2014","journal-title":"Oncol. Res."},{"key":"10.1016\/j.addr.2022.114445_b0320","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13046-019-1234-8","article-title":"Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death","volume":"38","author":"Chen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.addr.2022.114445_b0325","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.4161\/cbt.7.7.6036","article-title":"Synergistic effects of the purine analog sulfinosine and curcumin on the multidrug resistant human non-small cell lung carcinoma cell line","volume":"7","author":"Andjelkovic","year":"2008","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.addr.2022.114445_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2019.114662","article-title":"Degradation of MCL-1 by bufalin reverses acquired resistance to osimertinib in EGFR-mutant lung cancer","volume":"379","author":"Cao","year":"2019","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0335","doi-asserted-by":"crossref","unstructured":"X.H. Kang, Z.Y. Xu, Y.B. Gong, L.F. Wang, Z.Q. Wang, L. Xu, F. Cao, M.J. Liao, Bufalin Reverses HGF-Induced Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer Cells via Blockage of Met\/PI3k\/Akt Pathway and Induction of Apoptosis, Evid Based Complement Alternat. Med., 2013 (2013) 243859.","DOI":"10.1155\/2013\/243859"},{"key":"10.1016\/j.addr.2022.114445_b0340","first-page":"490","article-title":"Bufalin reverses hepatocyte growth factor-induced resistance to afatinib in H1975 lung cancer cells","volume":"37","author":"Kang","year":"2015","journal-title":"Zhonghua Zhong Liu Za Zhi"},{"key":"10.1016\/j.addr.2022.114445_b0345","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.2147\/OTT.S100936","article-title":"Combination of gambogic acid with cisplatin enhances the antitumor effects on cisplatin-resistant lung cancer cells by downregulating MRP2 and LRP expression","volume":"9","author":"Zhang","year":"2016","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.addr.2022.114445_b0350","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.3892\/ol.2015.3599","article-title":"Combined therapy with EGFR TKI and gambogic acid for overcoming resistance in EGFR-T790M mutant lung cancer","volume":"10","author":"Wang","year":"2015","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.addr.2022.114445_b0355","first-page":"3380","article-title":"Preliminary evaluation of the potential role of beta-elemene in reversing erlotinib-resistant human NSCLC A549\/ER cells","volume":"16","author":"Lin","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.addr.2022.114445_b0360","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.biopha.2014.12.016","article-title":"Green tea polyphenol EGCG reverse cisplatin resistance of A549\/DDP cell line through candidate genes demethylation","volume":"69","author":"Zhang","year":"2015","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2022.114445_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.115380","article-title":"Co-administration of Luteolin mitigated toxicity in rats' lungs associated with doxorubicin treatment","volume":"411","author":"Owumi","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0370","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fphar.2019.00182","article-title":"Herbal Medicines for Irinotecan-Induced Diarrhea","volume":"10","author":"Tang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0375","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/749495","article-title":"Chinese herbal medicine banxiaxiexin decoction treating diabetic gastroparesis: a systematic review of randomized controlled trials","volume":"2013","author":"Tian","year":"2013","journal-title":"Evid Based Complement Alternat. Med."},{"key":"10.1016\/j.addr.2022.114445_b0380","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1177\/1534735418801532","article-title":"Banxia Xiexin Decoction Is Effective to Prevent and Control Irinotecan-Induced Delayed Diarrhea in Recurrent Small Cell Lung Cancer","volume":"17","author":"Lu","year":"2018","journal-title":"Integr. Cancer Ther."},{"key":"10.1016\/j.addr.2022.114445_b0385","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1756-9966-29-137","article-title":"Shenqi fuzheng, an injection concocted from Chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review","volume":"29","author":"Dong","year":"2010","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.addr.2022.114445_b0390","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.2147\/DDDT.S241291","article-title":"Combination Therapy of Lung Cancer Using Layer-by-Layer Cisplatin Prodrug and Curcumin Co-Encapsulated Nanomedicine","volume":"14","author":"Hong","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"10.1016\/j.addr.2022.114445_b0395","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108614","article-title":"Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine","volume":"112","author":"Hong","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2022.114445_b0400","doi-asserted-by":"crossref","first-page":"4519","DOI":"10.2147\/DDDT.S251749","article-title":"Lung Cancer Combination Treatment: Evaluation of the Synergistic Effect of Cisplatin Prodrug, Vinorelbine and Retinoic Acid When Co-Encapsulated in a Multi-Layered Nano-Platform","volume":"14","author":"Liang","year":"2020","journal-title":"Drug Des. Devel Ther."},{"issue":"1","key":"10.1016\/j.addr.2022.114445_b0405","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3390\/cancers12010048","article-title":"Honokiol: A Review of Its Anticancer Potential and Mechanisms","volume":"12","author":"Ong","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.addr.2022.114445_b0410","first-page":"957","article-title":"Synergistic antitumor effects of liposomal honokiol combined with cisplatin in colon cancer models","volume":"2","author":"Cheng","year":"2011","journal-title":"Oncol. Lett."},{"issue":"9","key":"10.1016\/j.addr.2022.114445_b0415","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1093\/abbs\/gmt071","article-title":"Honokiol augments the anti-cancer effects of oxaliplatin in colon cancer cells","volume":"45","author":"Hua","year":"2013","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"key":"10.1016\/j.addr.2022.114445_b0420","first-page":"246","article-title":"Ursolic acid potentiated oxaliplatin to induce apoptosis in colorectal cancer RKO cells","volume":"75","author":"Zheng","year":"2020","journal-title":"Pharmazie"},{"issue":"8","key":"10.1016\/j.addr.2022.114445_b0425","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s13238-016-0295-0","article-title":"Ursolic acid synergistically enhances the therapeutic effects of oxaliplatin in colorectal cancer","volume":"7","author":"Shan","year":"2016","journal-title":"Protein Cell"},{"key":"10.1016\/j.addr.2022.114445_b0430","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/cas.13425","article-title":"Ursolic acid enhances the therapeutic effects of oxaliplatin in colorectal cancer by inhibition of drug resistance","volume":"109","author":"Zhang","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.addr.2022.114445_b0435","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.7150\/thno.44705","article-title":"Combinative treatment of beta-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.addr.2022.114445_b0440","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/0929867324666170111152436","article-title":"Colorectal Cancer Chemotherapy: The Evolution of Treatment and New Approaches","volume":"24","author":"McQuade","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2022.114445_b0445","doi-asserted-by":"crossref","first-page":"3269","DOI":"10.1007\/s00415-020-09942-w","article-title":"Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment","volume":"268","author":"Kang","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.addr.2022.114445_b0450","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1186\/s13046-017-0661-7","article-title":"Curcumin synergizes with 5-fluorouracil by impairing AMPK\/ULK1-dependent autophagy, AKT activity and enhancing apoptosis in colon cancer cells with tumor growth inhibition in xenograft mice","volume":"36","author":"Zhang","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.addr.2022.114445_b0455","first-page":"8019","article-title":"Bufalin and 5-fluorouracil synergistically induce apoptosis in colorectal cancer cells","volume":"15","author":"Dai","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.addr.2022.114445_b0460","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00280-015-2749-0","article-title":"Gossypol sensitizes the antitumor activity of 5-FU through down-regulation of thymidylate synthase in human colon carcinoma cells","volume":"76","author":"Yang","year":"2015","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2020.111529","article-title":"Synergistic therapy with tangeretin and 5-fluorouracil accelerates the ROS\/JNK mediated apoptotic pathway in human colorectal cancer cell","volume":"143","author":"Dey","year":"2020","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.addr.2022.114445_b0470","doi-asserted-by":"crossref","first-page":"662","DOI":"10.3892\/etm.2017.4021","article-title":"Gambogic acid potentiates the chemosensitivity of colorectal cancer cells to 5-fluorouracil by inhibiting proliferation and inducing apoptosis","volume":"13","author":"Wei","year":"2017","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.addr.2022.114445_b0475","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00280-011-1641-9","article-title":"Quercetin enhances 5-fluorouracil-induced apoptosis in MSI colorectal cancer cells through p53 modulation","volume":"68","author":"Xavier","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0480","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.canlet.2009.10.013","article-title":"Triptolide simultaneously induces reactive oxygen species, inhibits NF-kappaB activity and sensitizes 5-fluorouracil in colorectal cancer cell lines","volume":"291","author":"Xu","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2022.114445_b0485","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/ptr.5257","article-title":"Curcumin combined with oxaliplatin effectively suppress colorectal carcinoma in vivo through inducing apoptosis","volume":"29","author":"Guo","year":"2015","journal-title":"Phytother. Res."},{"key":"10.1016\/j.addr.2022.114445_b0490","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00280-010-1413-y","article-title":"Sulforaphane potentiates oxaliplatin-induced cell growth inhibition in colorectal cancer cells via induction of different modes of cell death","volume":"67","author":"Kaminski","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0495","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1002\/ijc.24593","article-title":"Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model","volume":"125","author":"Kunnumakkara","year":"2009","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2022.114445_b0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110381","article-title":"Curcumin may reverse 5-fluorouracil resistance on colonic cancer cells by regulating TET1-NKD-Wnt signal pathway to inhibit the EMT progress","volume":"129","author":"Lu","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2022.114445_b0505","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1007\/s11010-020-03856-x","article-title":"LncRNA KCNQ1OT1 is a key factor in the reversal effect of curcumin on cisplatin resistance in the colorectal cancer cells","volume":"476","author":"Zheng","year":"2021","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.addr.2022.114445_b0510","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s11655-018-2997-z","article-title":"Curcumin Reverses 5-Fluorouracil Resistance by Promoting Human Colon Cancer HCT-8\/5-FU Cell Apoptosis and Down-regulating Heat Shock Protein 27 and P-Glycoprotein","volume":"25","author":"He","year":"2019","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.addr.2022.114445_b0515","doi-asserted-by":"crossref","first-page":"3893","DOI":"10.2147\/OTT.S199601","article-title":"Curcumin reverses oxaliplatin resistance in human colorectal cancer via regulation of TGF-beta\/Smad2\/3 signaling pathway","volume":"12","author":"Yin","year":"2019","journal-title":"Onco Targets Ther."},{"key":"10.1016\/j.addr.2022.114445_b0520","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ijc.25670","article-title":"Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo","volume":"129","author":"Howells","year":"2011","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.addr.2022.114445_b0525","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phymed.2018.06.046","article-title":"Resveratrol mediated cancer cell apoptosis, and modulation of multidrug resistance proteins and metabolic enzymes","volume":"55","author":"El-Readi","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2022.114445_b0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173185","article-title":"Quercetin overcomes colon cancer cells resistance to chemotherapy by inhibiting solute carrier family 1, member 5 transporter","volume":"881","author":"Zhou","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0535","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3389\/fbioe.2020.00378","article-title":"beta-Elemene Reverses the Resistance of p53-Deficient Colorectal Cancer Cells to 5-Fluorouracil by Inducing Pro-death Autophagy and Cyclin D3-Dependent Cycle Arrest","volume":"8","author":"Zhang","year":"2020","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.addr.2022.114445_b0540","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.3748\/wjg.v20.i14.3751","article-title":"Gastro-intestinal toxicity of chemotherapeutics in colorectal cancer: the role of inflammation","volume":"20","author":"Lee","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.addr.2022.114445_b0545","doi-asserted-by":"crossref","first-page":"E40","DOI":"10.1097\/NCC.0000000000000674","article-title":"Oxaliplatin-Induced Neurotoxic Side Effects and Their Impact on Daily Activities: A Longitudinal Study Among Patients With Colorectal Cancer","volume":"42","author":"Drott","year":"2019","journal-title":"Cancer Nurs."},{"key":"10.1016\/j.addr.2022.114445_b0550","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/ptr.5149","article-title":"Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial","volume":"28","author":"Panahi","year":"2014","journal-title":"Phytother. Res."},{"key":"10.1016\/j.addr.2022.114445_b0555","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/jop.12481","article-title":"Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells","volume":"46","author":"Ji","year":"2017","journal-title":"J. Oral Pathol. Med."},{"issue":"6","key":"10.1016\/j.addr.2022.114445_b0560","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.3390\/molecules24061177","article-title":"Neuroprotective Effects of an Aqueous Extract of Forsythia viridissima and Its Major Constituents on Oxaliplatin-Induced Peripheral Neuropathy","volume":"24","author":"Yi","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2022.114445_b0565","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2147\/DDDT.S262818","article-title":"Network Pharmacology and Experimental Evidence Identify the Mechanism of Astragaloside IV in Oxaliplatin Neurotoxicity","volume":"15","author":"Xu","year":"2021","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.addr.2022.114445_b0570","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3389\/fphar.2017.00211","article-title":"Quantitative Evaluation of the Compatibility Effects of Huangqin Decoction on the Treatment of Irinotecan-Induced Gastrointestinal Toxicity Using Untargeted Metabolomics","volume":"8","author":"Cui","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0575","doi-asserted-by":"crossref","unstructured":"W. Lam, S. Bussom, F. Guan, Z. Jiang, W. Zhang, E.A. Gullen, S.H. Liu, Y.C. Cheng, The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity, Sci. Transl. Med., 2 (2010) 45ra59.","DOI":"10.1126\/scitranslmed.3001270"},{"key":"10.1016\/j.addr.2022.114445_b0580","doi-asserted-by":"crossref","first-page":"777","DOI":"10.2174\/1389450111314070007","article-title":"Therapeutic targeting of CPT-11 induced diarrhea: a case for prophylaxis","volume":"14","author":"Swami","year":"2013","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.addr.2022.114445_b0585","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1349-7006.1995.tb03010.x","article-title":"Protective effects of kampo medicines and baicalin against intestinal toxicity of a new anticancer camptothecin derivative, irinotecan hydrochloride (CPT-11), in rats","volume":"86","author":"Takasuna","year":"1995","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.addr.2022.114445_b0590","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0254-6272(17)30024-9","article-title":"Effects of Shengjiangxiexin decoction on irinotecan-induced toxicity in patients with UGT1A1*28 and UGT1A1*6 polymorphisms","volume":"37","author":"Deng","year":"2017","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.addr.2022.114445_b0595","article-title":"Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3- gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles","volume":"21","author":"Wang","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.addr.2022.114445_b0600","first-page":"2730","article-title":"Combinatorial anticancer effects of curcumin and 5-fluorouracil loaded thiolated chitosan nanoparticles towards colon cancer treatment","volume":"2014","author":"Anitha","year":"1840","journal-title":"Biochim. Biophys. Acta, Mol. Cell. Biol. Lipids"},{"key":"10.1016\/j.addr.2022.114445_b0605","doi-asserted-by":"crossref","unstructured":"A. Anitha, M. Sreeranganathan, K.P. Chennazhi, V.K. Lakshmanan, R. Jayakumar, Corrigendum to \u201cIn vitro combinatorial anticancer effects of 5-fluorouracil and curcumin loaded N,O-carboxymethyl chitosan nanoparticles toward colon cancer and in vivo pharmacokinetic studies\u201d [Eur. J. Pharmaceut. Biopharmaceut. 88 (2014) 238-251], Eur J Pharm Biopharm, 139 (2019) 44-46.","DOI":"10.1016\/j.ejpb.2019.03.009"},{"key":"10.1016\/j.addr.2022.114445_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2021.105864","article-title":"In vitro and in vivo combinatorial anticancer effects of oxaliplatin- and resveratrol-loaded N, O-carboxymethyl chitosan nanoparticles against colorectal cancer","volume":"163","author":"Wang","year":"2021","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114445_b0615","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.phytochem.2017.09.016","article-title":"Chrysin: Sources, beneficial pharmacological activities, and molecular mechanism of action","volume":"145","author":"Mani","year":"2018","journal-title":"Phytochemistry"},{"key":"10.1016\/j.addr.2022.114445_b0620","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cbi.2015.03.003","article-title":"Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53","volume":"232","author":"Li","year":"2015","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.addr.2022.114445_b0625","doi-asserted-by":"crossref","first-page":"695","DOI":"10.21873\/anticanres.13165","article-title":"Chrysin-induced ERK1\/2 Phosphorylation Enhances the Sensitivity of Human Hepatocellular Carcinoma Cells to Sorafenib","volume":"39","author":"Wei","year":"2019","journal-title":"Anticancer Res."},{"issue":"5","key":"10.1016\/j.addr.2022.114445_b0630","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.3390\/ijms19051518","article-title":"Chlorogenic Acid Improves the Regorafenib Effects in Human Hepatocellular Carcinoma Cells","volume":"19","author":"Refolo","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2022.114445_b0635","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/CAD.0000000000000218","article-title":"Chlorogenic acid enhances the effects of 5-fluorouracil in human hepatocellular carcinoma cells through the inhibition of extracellular signal-regulated kinases","volume":"26","author":"Yan","year":"2015","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.addr.2022.114445_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107879","article-title":"Celastrol inhibits rheumatoid arthritis through the ROS-NF-kappaB-NLRP3 inflammasome axis","volume":"98","author":"Jing","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0645","first-page":"412","article-title":"Celastrol enhanced the anticancer effect of lapatinib in human hepatocellular carcinoma cells in vitro","volume":"19","author":"Yan","year":"2014","journal-title":"J. Buon"},{"issue":"12","key":"10.1016\/j.addr.2022.114445_b0650","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052333","article-title":"Upregulating Noxa by ER stress, celastrol exerts synergistic anti-cancer activity in combination with ABT-737 in human hepatocellular carcinoma cells","volume":"7","author":"Zhu","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114445_b0655","first-page":"353","article-title":"The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cells","volume":"16","author":"Li","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.addr.2022.114445_b0660","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.3892\/or.2018.6754","article-title":"Capsaicin and sorafenib combination treatment exerts synergistic antihepatocellular carcinoma activity by suppressing EGFR and PI3K\/Akt\/mTOR signaling","volume":"40","author":"Dai","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.addr.2022.114445_b0665","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s11033-011-0908-x","article-title":"Bufalin enhances the anti-proliferative effect of sorafenib on human hepatocellular carcinoma cells through downregulation of ERK","volume":"39","author":"Gao","year":"2012","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.addr.2022.114445_b0670","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ejphar.2018.05.027","article-title":"Combined treatment with sorafenib and silibinin synergistically targets both HCC cells and cancer stem cells by enhanced inhibition of the phosphorylation of STAT3\/ERK\/AKT","volume":"832","author":"Mao","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0675","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbrc.2019.08.115","article-title":"Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma","volume":"519","author":"Jing","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2022.114445_b0680","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3892\/or.2013.2817","article-title":"Reversal effect of bufalin on multidrug resistance in human hepatocellular carcinoma BEL-7402\/5-FU cells","volume":"31","author":"Gu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.addr.2022.114445_b0685","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1158\/0008-5472.CAN-05-1568","article-title":"Sulforaphane sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-resistant hepatoma cells to TRAIL-induced apoptosis through reactive oxygen species-mediated up-regulation of DR5","volume":"66","author":"Kim","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.addr.2022.114445_b0690","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/14786419.2019.1598991","article-title":"Inhibitory effects and molecular mechanisms of pentagalloyl glucose in combination with 5-FU on aggressive phenotypes of HepG2 cells","volume":"35","author":"Ding","year":"2021","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.addr.2022.114445_b0695","first-page":"1465","article-title":"The combination of glycyrrhizin and lamivudine can reverse the cisplatin resistance in hepatocellular carcinoma cells through inhibition of multidrug resistance-associated proteins","volume":"31","author":"Wakamatsu","year":"2007","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.addr.2022.114445_b0700","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.canlet.2016.04.037","article-title":"Polysaccharide from Lentinus edodes combined with oxaliplatin possesses the synergy and attenuation effect in hepatocellular carcinoma","volume":"377","author":"Zhang","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2022.114445_b0705","doi-asserted-by":"crossref","first-page":"9384","DOI":"10.1038\/srep09384","article-title":"PHY906(KD018), an adjuvant based on a 1800-year-old Chinese medicine, enhanced the anti-tumor activity of Sorafenib by changing the tumor microenvironment","volume":"5","author":"Lam","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2022.114445_b0710","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jep.2012.01.047","article-title":"Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy","volume":"140","author":"Liu","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0715","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1755-8794-4-38","article-title":"Interaction of a traditional Chinese Medicine (PHY906) and CPT-11 on the inflammatory process in the tumor microenvironment","volume":"4","author":"Wang","year":"2011","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.addr.2022.114445_b0720","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.colsurfb.2016.05.070","article-title":"Effective co-delivery of doxorubicin and curcumin using a glycyrrhetinic acid-modified chitosan-cystamine-poly(epsilon-caprolactone) copolymer micelle for combination cancer chemotherapy","volume":"145","author":"Yan","year":"2016","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.addr.2022.114445_b0725","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2017.07.030","article-title":"Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex","volume":"143","author":"Zhao","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2022.114445_b0730","doi-asserted-by":"crossref","first-page":"647","DOI":"10.2147\/DDDT.S238955","article-title":"Targeted Therapy for Hepatocellular Carcinoma: Co-Delivery of Sorafenib and Curcumin Using Lactosylated pH-Responsive Nanoparticles","volume":"14","author":"Bian","year":"2020","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.addr.2022.114445_b0735","first-page":"938","article-title":"cancer","volume":"62","author":"Banerjee","year":"2010","journal-title":"Review on molecular and therapeutic potential of thymoquinone in cancer"},{"key":"10.1016\/j.addr.2022.114445_b0740","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1007\/s13277-015-4307-0","article-title":"The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer","volume":"37","author":"Sakalar","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.addr.2022.114445_b0745","doi-asserted-by":"crossref","unstructured":"H. Bashmail, A. Alamoudi, A. Noorwali, G. Hegazy, G. AJabnoor, H. Choudhry, A.J.S.r. Al-Abd, Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities, 8 (2018) 11674.","DOI":"10.1038\/s41598-018-30046-z"},{"issue":"10","key":"10.1016\/j.addr.2022.114445_b0750","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0075356","article-title":"Thymoquinone inhibits tumor growth and induces apoptosis in a breast cancer xenograft mouse model: the role of p38 MAPK and ROS","volume":"8","author":"Woo","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114445_b0755","doi-asserted-by":"crossref","unstructured":"S. Kim, H. Park, D.J.O.l. Moon, Sulforaphane sensitizes human breast cancer cells to paclitaxel-induced apoptosis by downregulating the NF-\u03baB signaling pathway, 13 (2017) 4427-4432.","DOI":"10.3892\/ol.2017.5950"},{"key":"10.1016\/j.addr.2022.114445_b0760","doi-asserted-by":"crossref","unstructured":"C. Bose, S. Awasthi, R. Sharma, H. Bene\u0161, M. Hauer-Jensen, M. Boerma, S.J.P.o. Singh, Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model, 13 (2018) e0193918.","DOI":"10.1371\/journal.pone.0193918"},{"key":"10.1016\/j.addr.2022.114445_b0765","doi-asserted-by":"crossref","unstructured":"J. Burnett, G. Lim, Y. Li, R. Shah, R. Lim, H. Paholak, S. McDermott, L. Sun, Y. Tsume, S. Bai, M. Wicha, D. Sun, T.J.C.l. Zhang, Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells, 394 (2017) 52-64.","DOI":"10.1016\/j.canlet.2017.02.023"},{"key":"10.1016\/j.addr.2022.114445_b0770","doi-asserted-by":"crossref","unstructured":"M. Milczarek, K. Wiktorska, L. Mielczarek, M. Koronkiewicz, A. D\u0105browska, K. Lubelska, D. Matosiuk, Z.J.F. Chilmonczyk, c.t.a.i.j.p.f.t.B.I.B.R. Association, Autophagic cell death and premature senescence: New mechanism of 5-fluorouracil and sulforaphane synergistic anticancer effect in MDA-MB-231 triple negative breast cancer cell line, 111 (2018) 1-8.","DOI":"10.1016\/j.fct.2017.10.056"},{"key":"10.1016\/j.addr.2022.114445_b0775","doi-asserted-by":"crossref","unstructured":"L. Chakrawarti, R. Agrawal, S. Dang, S. Gupta, R.J.E.o.o.t.p. Gabrani, Therapeutic effects of EGCG: a patent review, 26 (2016) 907-916.","DOI":"10.1080\/13543776.2016.1203419"},{"key":"10.1016\/j.addr.2022.114445_b0780","doi-asserted-by":"crossref","unstructured":"Y. Zhou, J. Tang, Y. Du, J. Ding, J.J.T.b.t.j.o.t.I.S.f.O.B. Liu, Medicine, The green tea polyphenol EGCG potentiates the antiproliferative activity of sunitinib in human cancer cells, 37 (2016) 8555-8566.","DOI":"10.1007\/s13277-015-4719-x"},{"key":"10.1016\/j.addr.2022.114445_b0785","doi-asserted-by":"crossref","unstructured":"E. Ozkan, F.J.A.d.A.B.d.C. Bakar-Ates, Potentiation of the Effect of Lonidamine by Quercetin in MCF-7 human breast cancer cells through downregulation of MMP-2\/9 mRNA Expression, 92 (2020) e20200548.","DOI":"10.1590\/0001-3765202020200548"},{"key":"10.1016\/j.addr.2022.114445_b0790","doi-asserted-by":"crossref","unstructured":"J. Vargas, R. Puga, G. Lenz, C. Trindade, E.J.O.m. Filippi-Chiela, c. longevity, Cellular Mechanisms Triggered by the Cotreatment of Resveratrol and Doxorubicin in Breast Cancer: A Translational In Vitro-In Silico Model, 2020 (2020) 5432651.","DOI":"10.1155\/2020\/5432651"},{"issue":"4","key":"10.1016\/j.addr.2022.114445_b0795","volume":"9","author":"Li","year":"2014","journal-title":"Sensitizing the therapeutic efficacy of taxol with shikonin in human breast cancer cells"},{"key":"10.1016\/j.addr.2022.114445_b0800","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082362","article-title":"Magnolol: A Neolignan from the Magnolia Family for the Prevention and Treatment of Cancer","volume":"19","author":"Ranaware","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2022.114445_b0805","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s00280-021-04238-w","article-title":"Honokiol antagonizes doxorubicin resistance in human breast cancer via miR-188-5p\/FBXW7\/c-Myc pathway","volume":"87","author":"Yi","year":"2021","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b0810","unstructured":"H. Han, L.J.A.r. Van Anh, Modulation of P-glycoprotein expression by honokiol, magnolol and 4-O-methylhonokiol, the bioactive components of Magnolia officinalis, 32 (2012) 4445-4452"},{"key":"10.1016\/j.addr.2022.114445_b0815","doi-asserted-by":"crossref","unstructured":"P. Thulasiraman, A.J.I.j.o.o. Johnson, Regulation of Mucin 1 and multidrug resistance protein 1 by honokiol enhances the efficacy of doxorubicin-mediated growth suppression in mammary carcinoma cells, 49 (2016) 479-486.","DOI":"10.3892\/ijo.2016.3534"},{"key":"10.1016\/j.addr.2022.114445_b0820","doi-asserted-by":"crossref","unstructured":"S. Liu, R. Li, J. Qian, J. Sun, G. Li, J. Shen, Y.J.M.p. Xie, Combination Therapy of Doxorubicin and Quercetin on Multidrug-Resistant Breast Cancer and Their Sequential Delivery by Reduction-Sensitive Hyaluronic Acid-Based Conjugate\/d-\u03b1-Tocopheryl Poly(ethylene glycol) 1000 Succinate Mixed Micelles, 17 (2020) 1415-1427.","DOI":"10.1021\/acs.molpharmaceut.0c00138"},{"key":"10.1016\/j.addr.2022.114445_b0825","doi-asserted-by":"crossref","unstructured":"G. Du, H. Lin, M. Wang, S. Zhang, X. Wu, L. Lu, L. Ji, L.J.C.c. Yu, pharmacology, Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1\u03b1 in tumor and normal cells, 65 (2010) 277-287.","DOI":"10.1007\/s00280-009-1032-7"},{"key":"10.1016\/j.addr.2022.114445_b0830","doi-asserted-by":"crossref","unstructured":"B. Zhai, N. Zhang, X. Han, Q. Li, M. Zhang, X. Chen, G. Li, R. Zhang, P. Chen, W. Wang, C. Li, Y. Xiang, S. Liu, T. Duan, J. Lou, T. Xie, X.J.B. Sui, p. Biomedecine, pharmacotherapie, Molecular targets of \u03b2-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: A review, 114 (2019) 108812.","DOI":"10.1016\/j.biopha.2019.108812"},{"issue":"2","key":"10.1016\/j.addr.2022.114445_b0835","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s10549-012-2263-6","article-title":"Investigation of elemene-induced reversal of tamoxifen resistance in MCF-7 cells through oestrogen receptor \u03b1 (ER\u03b1) re-expression","volume":"136","author":"Zhang","year":"2012","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.addr.2022.114445_b0840","doi-asserted-by":"crossref","unstructured":"J. Zhang, H. Zhang, Y. Yao, S. Zhong, J. Zhao, J.J.C.p. Tang, b. biochemistry : international journal of experimental cellular physiology, pharmacology, \u03b2-Elemene Reverses Chemoresistance of Breast Cancer Cells by Reducing Resistance Transmission via Exosomes, 36 (2015) 2274\u20132286.","DOI":"10.1159\/000430191"},{"key":"10.1016\/j.addr.2022.114445_b0845","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.colsurfb.2019.04.023","article-title":"Hierarchical bioresponsive nanocarriers for codelivery of curcumin and doxorubicin","volume":"180","author":"Lin","year":"2019","journal-title":"Colloids Surf. B"},{"issue":"51","key":"10.1016\/j.addr.2022.114445_b0850","first-page":"88658","volume":"8","author":"Zhang","year":"2017","journal-title":"Shikonin reduces tamoxifen resistance through long non-coding RNA uc.57"},{"key":"10.1016\/j.addr.2022.114445_b0855","doi-asserted-by":"crossref","unstructured":"L. Zong, G. Cheng, S. Liu, Z. Pi, Z. Liu, F.J.J.o.p. Song, b. analysis, Reversal of multidrug resistance in breast cancer cells by a combination of ursolic acid with doxorubicin, 165 (2019) 268-275.","DOI":"10.1016\/j.jpba.2018.11.057"},{"key":"10.1016\/j.addr.2022.114445_b0860","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/ptr.6353","article-title":"Combination of tanshinone IIA and doxorubicin possesses synergism and attenuation effects on doxorubicin in the treatment of breast cancer","volume":"33","author":"Li","year":"2019","journal-title":"Phytother. Res."},{"key":"10.1016\/j.addr.2022.114445_b0865","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1089\/jmf.2013.0086","article-title":"Curcumin reduces cytotoxicity of 5-Fluorouracil treatment in human breast cancer cells","volume":"18","author":"Ferguson","year":"2015","journal-title":"J. Med. Food"},{"key":"10.1016\/j.addr.2022.114445_b0870","doi-asserted-by":"crossref","unstructured":"J. Meng, F. Guo, H. Xu, W. Liang, C. Wang, X.J.S.r. Yang, Combination Therapy using Co-encapsulated Resveratrol and Paclitaxel in Liposomes for Drug Resistance Reversal in Breast Cancer Cells in vivo, 6 (2016) 22390.","DOI":"10.1038\/srep22390"},{"key":"10.1016\/j.addr.2022.114445_b0875","doi-asserted-by":"crossref","DOI":"10.1016\/j.carbpol.2020.115981","article-title":"Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer","volume":"235","author":"Wang","year":"2020","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.addr.2022.114445_b0880","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111284","article-title":"Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer","volume":"196","author":"Liu","year":"2020","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.addr.2022.114445_b0885","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.601649","article-title":"Co-delivery of Salinomycin and Curcumin for Cancer Stem Cell Treatment by Inhibition of Cell Proliferation, Cell Cycle Arrest, and Epithelial-Mesenchymal Transition","volume":"8","author":"Zhao","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2022.114445_b0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2019.110515","article-title":"Methotrexate and Curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation","volume":"184","author":"Vakilinezhad","year":"2019","journal-title":"Colloids Surf. B"},{"issue":"6","key":"10.1016\/j.addr.2022.114445_b0895","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.nano.2015.03.015","article-title":"Sequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core\/shell nanoparticles sensitizes drug-resistant breast cancer cells","volume":"11","author":"Narayanan","year":"2015","journal-title":"Nanomedicine"},{"issue":"5","key":"10.1016\/j.addr.2022.114445_b0900","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1016\/j.actbio.2013.12.041","article-title":"Sequentially releasing dual-drug-loaded PLGA-casein core\/shell nanomedicine: design, synthesis, biocompatibility and pharmacokinetics","volume":"10","author":"Narayanan","year":"2014","journal-title":"Acta Biomater."},{"key":"10.1016\/j.addr.2022.114445_b0905","doi-asserted-by":"crossref","first-page":"3459","DOI":"10.1021\/mp400311j","article-title":"Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity","volume":"10","author":"Jain","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2022.114445_b0910","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ijpharm.2017.03.040","article-title":"Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel\/quercetin-loaded nanoparticles via Akt\/MMP-9 pathway","volume":"523","author":"Li","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114445_b0915","doi-asserted-by":"crossref","first-page":"35267","DOI":"10.1038\/srep35267","article-title":"Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance","volume":"6","author":"Zhao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.addr.2022.114445_b0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105070","article-title":"PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden","volume":"140","author":"Gao","year":"2019","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114445_b0925","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijpharm.2017.10.043","article-title":"PEGylated Lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: Design, characterization and its cytotoxic effect","volume":"536","author":"Lin","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114445_b0930","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jcis.2017.08.097","article-title":"Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7\/ADR cells","volume":"509","author":"Zhang","year":"2018","journal-title":"J. Colloid Interface Sci."},{"issue":"7","key":"10.1016\/j.addr.2022.114445_b0935","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1021\/acs.molpharmaceut.6b00183","article-title":"Conjugation of Docetaxel with Multiwalled Carbon Nanotubes and Codelivery with Piperine: Implications on Pharmacokinetic Profile and Anticancer Activity","volume":"13","author":"Raza","year":"2016","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.addr.2022.114445_b0940","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.msec.2018.03.033","article-title":"N-desmethyl tamoxifen and quercetin-loaded multiwalled CNTs: A synergistic approach to overcome MDR in cancer cells","volume":"89","author":"Kumar","year":"2018","journal-title":"Mater. Sci. Eng., C"},{"issue":"49","key":"10.1016\/j.addr.2022.114445_b0945","doi-asserted-by":"crossref","first-page":"85926","DOI":"10.18632\/oncotarget.20721","article-title":"Enhancing conventional chemotherapy drug cisplatin-induced anti-tumor effects on human gastric cancer cells both in vitro and in vivo by Thymoquinone targeting PTEN gene","volume":"8","author":"Ma","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.addr.2022.114445_b0950","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.bbrc.2011.12.063","article-title":"Thymoquinone inhibits growth and augments 5-fluorouracil-induced apoptosis in gastric cancer cells both in vitro and in vivo","volume":"417","author":"Lei","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.addr.2022.114445_b0955","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3892\/ol.2017.5614","article-title":"Antitumor effects and the underlying mechanism of licochalcone A combined with 5-fluorouracil in gastric cancer cells","volume":"13","author":"Lin","year":"2017","journal-title":"Oncol Lett"},{"key":"10.1016\/j.addr.2022.114445_b0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153408","article-title":"Synergistic breast cancer suppression efficacy of doxorubicin by combination with glycyrrhetinic acid as an angiogenesis inhibitor","volume":"81","author":"Shi","year":"2021","journal-title":"Phytomedicine : Int. J. Phytotherapy and Phytopharmacology"},{"key":"10.1016\/j.addr.2022.114445_b0965","doi-asserted-by":"crossref","unstructured":"H. Yang, S. Huang, Y. Wei, S. Cao, C. Pi, T. Feng, J. Liang, L. Zhao, G.J.J.o.C. Ren, Curcumin Enhances the Anticancer Effect Of 5-fluorouracil against Gastric Cancer through Down-Regulation of COX-2 and NF- \u03baB Signaling Pathways, 8 (2017) 3697-3706.","DOI":"10.7150\/jca.20196"},{"issue":"21","key":"10.1016\/j.addr.2022.114445_b0970","doi-asserted-by":"crossref","first-page":"12525","DOI":"10.1111\/jcmm.15795","article-title":"Pterostilbene enhances sorafenib's anticancer effects on gastric adenocarcinoma","volume":"24","author":"Zhao","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.addr.2022.114445_b0975","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/9396512","article-title":"Luteolin Suppresses the Proliferation of Gastric Cancer Cells and Acts in Synergy with Oxaliplatin","volume":"2020","author":"Ren","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.addr.2022.114445_b0980","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11010-008-9749-x","article-title":"Anti-proliferative and chemosensitizing effects of luteolin on human gastric cancer AGS cell line","volume":"313","author":"Wu","year":"2008","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.addr.2022.114445_b0985","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.3389\/fphar.2020.01326","article-title":"Hesperetin Promotes Cisplatin-Induced Apoptosis of Gastric Cancer In Vitro and In Vivo by Upregulating PTEN Expression","volume":"11","author":"He","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"6","key":"10.1016\/j.addr.2022.114445_b0990","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22486","article-title":"Enhanced anticancer potency of doxorubicin in combination with curcumin in gastric adenocarcinoma","volume":"34","author":"Firouzi Amoodizaj","year":"2020","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.addr.2022.114445_b0995","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.tox.2008.11.014","article-title":"Synergistic effect of 5-fluorouracil with gambogic acid on BGC-823 human gastric carcinoma","volume":"256","author":"Wang","year":"2009","journal-title":"Toxicology"},{"key":"10.1016\/j.addr.2022.114445_b1000","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3389\/fphar.2018.01392","article-title":"Osthole Synergizes With HER2 Inhibitor, Trastuzumab in HER2-Overexpressed N87 Gastric Cancer by Inducing Apoptosis and Inhibition of AKT-MAPK Pathway","volume":"9","author":"Yang","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.addr.2022.114445_b1005","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1080\/10286020.2019.1645131","article-title":"The synergistic anti-tumor effect of schisandrin B and apatinib","volume":"22","author":"Li","year":"2020","journal-title":"J. Asian Nat. Prod. Res."},{"key":"10.1016\/j.addr.2022.114445_b1010","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3892\/ol.2014.2368","article-title":"Synergistic antitumor effects of combined deguelin and cisplatin treatment in gastric cancer cells","volume":"8","author":"Li","year":"2014","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.addr.2022.114445_b1015","doi-asserted-by":"crossref","first-page":"6981520","DOI":"10.1155\/2020\/6981520","article-title":"beta-Asarone Increases Chemosensitivity by Inhibiting Tumor Glycolysis in Gastric Cancer","volume":"2020","author":"Tao","year":"2020","journal-title":"Evid Based Complement Alternat. Med."},{"key":"10.1016\/j.addr.2022.114445_b1020","first-page":"1629","article-title":"The combination of crocin with cisplatin suppresses growth of gastric carcinoma cell line BGC-823 and promotes cell apoptosis","volume":"30","author":"Luo","year":"2017","journal-title":"Pak. J. Pharm. Sci."},{"issue":"23","key":"10.1016\/j.addr.2022.114445_b1025","doi-asserted-by":"crossref","first-page":"5843","DOI":"10.7150\/jca.31303","article-title":"Cucurbitacin E inhibits cellular proliferation and enhances the chemo-response in gastric cancer by suppressing AKt activation","volume":"10","author":"Si","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.addr.2022.114445_b1030","doi-asserted-by":"crossref","unstructured":"J. Xu, D. Liu, H. Niu, G. Zhu, Y. Xu, D. Ye, J. Li, Q.J.J.o.e. Zhang, c.c.r. CR, Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN\/Akt signaling pathway in gastric cancer, 36 (2017) 19.","DOI":"10.1186\/s13046-016-0487-8"},{"issue":"12","key":"10.1016\/j.addr.2022.114445_b1035","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050786","article-title":"Combination therapy with gossypol reveals synergism against gemcitabine resistance in cancer cells with high BCL-2 expression","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2022.114445_b1040","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10637-019-00781-9","article-title":"Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt\/beta-catenin signal pathway","volume":"38","author":"Hou","year":"2020","journal-title":"Invest. New Drugs"},{"issue":"47","key":"10.1016\/j.addr.2022.114445_b1045","doi-asserted-by":"crossref","first-page":"82842","DOI":"10.18632\/oncotarget.20666","article-title":"Reversal of 5-fluorouracil resistance by EGCG is mediate by inactivation of TFAP2A\/VEGF signaling pathway and down-regulation of MDR-1 and P-gp expression in gastric cancer","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"issue":"7","key":"10.1016\/j.addr.2022.114445_b1050","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/01635581.2011.607548","article-title":"Capsaicin induces apoptosis of cisplatin-resistant stomach cancer cells by causing degradation of cisplatin-inducible Aurora-A protein","volume":"63","author":"Huh","year":"2011","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.addr.2022.114445_b1055","first-page":"24","article-title":"Potentiating activities of chrysin in the therapeutic efficacy of 5-fluorouracil in gastric cancer cells","volume":"21","author":"Lee","year":"2021","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.addr.2022.114445_b1060","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.3892\/mmr.2016.5426","article-title":"Bufalin reverses intrinsic and acquired drug resistance to cisplatin through the AKT signaling pathway in gastric cancer cells","volume":"14","author":"Zhao","year":"2016","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.addr.2022.114445_b1065","doi-asserted-by":"crossref","first-page":"9266178","DOI":"10.1155\/2022\/9266178","article-title":"Protective Effects of Amauroderma rugosum on Doxorubicin-Induced Cardiotoxicity through Suppressing Oxidative Stress, Mitochondrial Dysfunction, Apoptosis, and Activating Akt\/mTOR and Nrf2\/HO-1 Signaling Pathways","volume":"2022","author":"Li","year":"2022","journal-title":"Oxid. Med. Cell. Longevity"},{"key":"10.1016\/j.addr.2022.114445_b1070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.canlet.2012.01.006","article-title":"Synergistic anticancer activity of triptolide combined with cisplatin enhances apoptosis in gastric cancer in vitro and in vivo","volume":"319","author":"Li","year":"2012","journal-title":"Cancer Lett."},{"key":"10.1016\/j.addr.2022.114445_b1075","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.toxlet.2010.05.019","article-title":"Wogonin potentiates the antitumor effects of low dose 5-fluorouracil against gastric cancer through induction of apoptosis by down-regulation of NF-kappaB and regulation of its metabolism","volume":"197","author":"Zhao","year":"2010","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.addr.2022.114445_b1080","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.phymed.2017.12.019","article-title":"Wogonin exacerbates the cytotoxic effect of oxaliplatin by inducing nitrosative stress and autophagy in human gastric cancer cells","volume":"39","author":"Hong","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.addr.2022.114445_b1085","doi-asserted-by":"crossref","first-page":"119","DOI":"10.29252\/ibj.24.2.119","article-title":"Synergistic Effect of Vitamin C with Cisplatin for Inhibiting Proliferation of Gastric Cancer Cells","volume":"24","author":"Ghavami","year":"2020","journal-title":"Iran. Biomed. J."},{"key":"10.1016\/j.addr.2022.114445_b1090","doi-asserted-by":"crossref","first-page":"5113","DOI":"10.2147\/IJN.S170862","article-title":"Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy","volume":"13","author":"Fang","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2022.114445_b1095","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.844426","article-title":"Reactive Oxygen Species-Responsive Nanococktail With Self-Amplificated Drug Release for Efficient Co-Delivery of Paclitaxel\/Cucurbitacin B and Synergistic Treatment of Gastric Cancer","volume":"10","author":"Pang","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.addr.2022.114445_b1100","first-page":"206","article-title":"A pH-sensitive supramolecular nanosystem with chlorin e6 and triptolide co-delivery for chemo-photodynamic combination therapy","volume":"17","author":"Wu","year":"2022","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.addr.2022.114445_b1105","first-page":"4685","article-title":"Genistein potentiates the antitumor effect of 5-Fluorouracil by inducing apoptosis and autophagy in human pancreatic cancer cells","volume":"34","author":"Suzuki","year":"2014","journal-title":"Anticancer Res."},{"key":"10.1016\/j.addr.2022.114445_b1110","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1208\/s12248-013-9558-3","article-title":"Antitumor activity of gemcitabine can be potentiated in pancreatic cancer through modulation of TLR4\/NF-kappaB signaling by 6-shogaol","volume":"16","author":"Zhou","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.addr.2022.114445_b1115","first-page":"5507","article-title":"Shikonin induces apoptosis and necroptosis in pancreatic cancer via regulating the expression of RIP1\/RIP3 and synergizes the activity of gemcitabine","volume":"9","author":"Chen","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.addr.2022.114445_b1120","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1007\/s10620-014-3394-x","article-title":"Thymoquinone Pretreatment Overcomes the Insensitivity and Potentiates the Antitumor Effect of Gemcitabine Through Abrogation of Notch1, PI3K\/Akt\/mTOR Regulated Signaling Pathways in Pancreatic Cancer","volume":"60","author":"Mu","year":"2015","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.addr.2022.114445_b1125","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/MPA.0b013e31824abdc0","article-title":"Triptolide cooperates with Cisplatin to induce apoptosis in gemcitabine-resistant pancreatic cancer","volume":"41","author":"Zhu","year":"2012","journal-title":"Pancreas"},{"key":"10.1016\/j.addr.2022.114445_b1130","doi-asserted-by":"crossref","unstructured":"C. Lan, S. Chen, C. Kuo, C. Lu, G.J.J.o.f. Yen, d. analysis, Quercetin facilitates cell death and chemosensitivity through RAGE\/PI3K\/AKT\/mTOR axis in human pancreatic cancer cells, 27 (2019) 887-896.","DOI":"10.1016\/j.jfda.2019.07.001"},{"key":"10.1016\/j.addr.2022.114445_b1135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijpharm.2018.09.016","article-title":"Comparative study of the therapeutic effect of Doxorubicin and Resveratrol combination on 2D and 3D (spheroids) cell culture models","volume":"551","author":"Barros","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2022.114445_b1140","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.3892\/ol.2016.4379","article-title":"Synergistic antitumor activity of gemcitabine combined with triptolide in pancreatic cancer cells","volume":"11","author":"Qiao","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.addr.2022.114445_b1145","doi-asserted-by":"crossref","DOI":"10.1016\/j.abb.2020.108546","article-title":"EGCG sensitizes chemotherapeutic-induced cytotoxicity by targeting the ERK pathway in multiple cancer cell lines","volume":"692","author":"Wei","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"issue":"Suppl 2","key":"10.1016\/j.addr.2022.114445_b1150","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.1016\/S0753-3322(05)80045-9","article-title":"Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells","volume":"59","author":"Lev-Ari","year":"2005","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.addr.2022.114445_b1155","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1097\/MPA.0000000000000215","article-title":"Luteolin and Gemcitabine Protect Against Pancreatic Cancer in an Orthotopic Mouse Model","volume":"44","author":"Johnson","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.addr.2022.114445_b1160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MPA.0b013e318193a074","article-title":"The flavonoid apigenin potentiates the growth inhibitory effects of gemcitabine and abrogates gemcitabine resistance in human pancreatic cancer cells","volume":"38","author":"Strouch","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.addr.2022.114445_b1165","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2011.13208","article-title":"Cyclopamine reverts acquired chemoresistance and down-regulates cancer stem cell markers in pancreatic cancer cell lines","volume":"141","author":"Yao","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.addr.2022.114445_b1170","first-page":"857","volume":"15","author":"Borska","year":"2010","journal-title":"Quercetin as a potential modulator of P-glycoprotein expression and function in cells of human pancreatic carcinoma line resistant to daunorubicin"},{"key":"10.1016\/j.addr.2022.114445_b1175","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/ptr.6669","article-title":"Ursolic acid promotes apoptosis, autophagy, and chemosensitivity in gemcitabine-resistant human pancreatic cancer cells","volume":"34","author":"Lin","year":"2020","journal-title":"Phytother. Res."},{"key":"10.1016\/j.addr.2022.114445_b1180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103234","article-title":"Sorafenib in Combination with Betulinic Acid Synergistically Induces Cell Cycle Arrest and Inhibits Clonogenic Activity in Pancreatic Ductal Adenocarcinoma Cells","volume":"19","author":"Kutkowska","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.addr.2022.114445_b1185","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26185583","article-title":"A Review on Preparation of Betulinic Acid and Its Biological Activities","volume":"26","author":"Lou","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.addr.2022.114445_b1190","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.msec.2019.01.026","article-title":"Gemcitabine and betulinic acid co-encapsulated PLGA-PEG polymer nanoparticles for improved efficacy of cancer chemotherapy","volume":"98","author":"Saneja","year":"2019","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"10.1016\/j.addr.2022.114445_b1195","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.biomaterials.2019.04.005","article-title":"Superparamagnetic iron oxide nanoparticles of curcumin enhance gemcitabine therapeutic response in pancreatic cancer","volume":"208","author":"Khan","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2022.114445_b1200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13578-015-0041-y","article-title":"Ferulic acid combined with aspirin demonstrates chemopreventive potential towards pancreatic cancer when delivered using chitosan-coated solid-lipid nanoparticles","volume":"5","author":"Thakkar","year":"2015","journal-title":"Cell Biosci"},{"key":"10.1016\/j.addr.2022.114445_b1205","first-page":"1023","volume":"14","author":"Pazhouhi","year":"2018","journal-title":"M.J.J.o.c.r. Khazaei, therapeutics, Synergistic effect of temozolomide and thymoquinone on human glioblastoma multiforme cell line (U87MG)"},{"key":"10.1016\/j.addr.2022.114445_b1210","doi-asserted-by":"crossref","unstructured":"M. Lee, C. Shi, Y. Hsu, K. Huang, S. Chen, P. Zhao, H. Chung, Y. Huang, Y.J.A.r. Lee, Honokiol Is a Potential Therapeutic Agent and Has a Synergistic Effect With 5-FU in Human Urothelial Cell Carcinoma Cells, 39 (2019) 6555-6565.","DOI":"10.21873\/anticanres.13871"},{"key":"10.1016\/j.addr.2022.114445_b1215","doi-asserted-by":"crossref","unstructured":"C. Chio, Y. Tai, M. Mohanraj, S. Liu, S. Yang, R.J.P.i.j.o.p. Chen, phytopharmacology, Honokiol enhances temozolomide-induced apoptotic insults to malignant glioma cells via an intrinsic mitochondrion-dependent pathway, 49 (2018) 41-51.","DOI":"10.1016\/j.phymed.2018.06.012"},{"key":"10.1016\/j.addr.2022.114445_b1220","first-page":"1794","volume":"106","author":"Ishitsuka","year":"2005","journal-title":"Honokiol overcomes conventional drug resistance in human multiple myeloma by induction of caspase-dependent and -independent apoptosis"},{"key":"10.1016\/j.addr.2022.114445_b1225","doi-asserted-by":"crossref","unstructured":"N. Ji, L. Jiang, P. Deng, H. Xu, F. Chen, J. Liu, J. Li, G. Liao, X. Zeng, Y. Lin, M. Feng, L. Li, Q.J.J.o.o.p. Chen, m.o.p.o.t.I.A.o.O. Pathologists, t.A.A.o.O. Pathology, Synergistic effect of honokiol and 5-fluorouracil on apoptosis of oral squamous cell carcinoma cells, 46 (2017) 201-207.","DOI":"10.1111\/jop.12481"},{"key":"10.1016\/j.addr.2022.114445_b1230","doi-asserted-by":"crossref","unstructured":"J. Guorgui, R. Wang, G. Mattheolabakis, G.J.A.o.b. Mackenzie, biophysics, Curcumin formulated in solid lipid nanoparticles has enhanced efficacy in Hodgkin's lymphoma in mice, 648 (2018) 12-19.","DOI":"10.1016\/j.abb.2018.04.012"},{"key":"10.1016\/j.addr.2022.114445_b1235","doi-asserted-by":"crossref","unstructured":"S. Sreenivasan, S.J.C.e.r. Krishnakumar, Synergistic Effect of Curcumin in Combination with Anticancer Agents in Human Retinoblastoma Cancer Cell Lines, 40 (2015) 1153-1165.","DOI":"10.3109\/02713683.2014.987870"},{"key":"10.1016\/j.addr.2022.114445_b1240","doi-asserted-by":"crossref","unstructured":"G. Kallifatidis, S. Labsch, V. Rausch, J. Mattern, J. Gladkich, G. Moldenhauer, M. B\u00fcchler, A. Salnikov, I.J.M.t.t.j.o.t.A.S.o.G.T. Herr, Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate, 19 (2011) 188-195.","DOI":"10.1038\/mt.2010.216"},{"key":"10.1016\/j.addr.2022.114445_b1245","doi-asserted-by":"crossref","unstructured":"S. Banerjee, S. Singh, I. Chowdhury, J. Lillard, R.J.F.i.b. Singh, Combinatorial effect of curcumin with docetaxel modulates apoptotic and cell survival molecules in prostate cancer, 9 (2017) 235-245.","DOI":"10.2741\/e798"},{"key":"10.1016\/j.addr.2022.114445_b1250","doi-asserted-by":"crossref","unstructured":"K. Jie, C. Wei, Z. Min, G. Ping, W. Ying, Z. Dan, Z.J.F.i.b. Sen, Resveratrol enhances chemosensitivity of renal cell carcinoma to paclitaxel, 24 (2019) 1452-1461.","DOI":"10.2741\/4790"},{"key":"10.1016\/j.addr.2022.114445_b1255","doi-asserted-by":"crossref","unstructured":"J. Jakubikova, D. Cervi, M. Ooi, K. Kim, S. Nahar, S. Klippel, D. Cholujova, M. Leiba, J. Daley, J. Delmore, J. Negri, S. Blotta, D. McMillin, T. Hideshima, P. Richardson, J. Sedlak, K. Anderson, C.J.H. Mitsiades, Anti-tumor activity and signaling events triggered by the isothiocyanates, sulforaphane and phenethyl isothiocyanate, in multiple myeloma, 96 (2011) 1170-1179.","DOI":"10.3324\/haematol.2010.029363"},{"key":"10.1016\/j.addr.2022.114445_b1260","doi-asserted-by":"crossref","unstructured":"C. Mayr, A. Wagner, D. Neureiter, M. Pichler, M. Jakab, R. Illig, F. Berr, T.J.B.c. Kiesslich, a. medicine, The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells, 15 (2015) 194.","DOI":"10.1186\/s12906-015-0721-5"},{"key":"10.1016\/j.addr.2022.114445_b1265","doi-asserted-by":"crossref","unstructured":"J. Jakubowicz-Gil, R. Paduch, T. Piersiak, K. G\u0142owniak, A. Gawron, M.J.B.p. Kandefer-Szersze\u0144, The effect of quercetin on pro-apoptotic activity of cisplatin in HeLa cells, 69 (2005) 1343-1350.","DOI":"10.1016\/j.bcp.2005.01.022"},{"key":"10.1016\/j.addr.2022.114445_b1270","doi-asserted-by":"crossref","unstructured":"B. Zhai, P. Chen, W. Wang, S. Liu, J. Feng, T. Duan, Y. Xiang, R. Zhang, M. Zhang, X. Han, X. Chen, Q. Li, G. Li, Y. Liu, X. Huang, W. Zhang, T. Pan, L. Yan, T. Jin, T. Xie, X.J.C.b. Sui, medicine, An ATF peptide-functionalized \u03b2-elemene-nanostructured lipid carrier combined with cisplatin for bladder cancer treatment, 17 (2020) 676-692.","DOI":"10.20892\/j.issn.2095-3941.2020.0454"},{"key":"10.1016\/j.addr.2022.114445_b1275","doi-asserted-by":"crossref","unstructured":"D. Gan, W. He, H. Yin, X.J.O.l. Gou, \u03b2-elemene enhances cisplatin-induced apoptosis in bladder cancer cells through the ROS-AMPK signaling pathway, 19 (2020) 291-300","DOI":"10.3892\/ol.2019.11103"},{"key":"10.1016\/j.addr.2022.114445_b1280","doi-asserted-by":"crossref","unstructured":"F. Xiaomeng, L. Lei, A. Jinghong, J. Juan, Y. Qi, Y.J.B.j.o.m. Dandan, b.r.R.b.d.p.m.e. biologicas, Treatment with \u03b2-elemene combined with paclitaxel inhibits growth, migration, and invasion and induces apoptosis of ovarian cancer cells by activation of STAT-NF-\u03baB pathway, 53 (2020) e8885.","DOI":"10.1590\/1414-431x20208885"},{"key":"10.1016\/j.addr.2022.114445_b1285","first-page":"63870","volume":"7","author":"Park","year":"2016","journal-title":"Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1\/2"},{"key":"10.1016\/j.addr.2022.114445_b1290","first-page":"45983","article-title":"X.J.S.r. Wu, Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to","volume":"7","author":"Wang","year":"2017","journal-title":"Cisplatin"},{"key":"10.1016\/j.addr.2022.114445_b1295","doi-asserted-by":"crossref","unstructured":"M. Roy, S.J.A.P.j.o.c.p.A. Mukherjee, Reversal of resistance towards cisplatin by curcumin in cervical cancer cells, 15 (2014) 1403-1410.","DOI":"10.7314\/APJCP.2014.15.3.1403"},{"key":"10.1016\/j.addr.2022.114445_b1300","doi-asserted-by":"crossref","unstructured":"X. Lu, F. Yang, D. Chen, Q. Zhao, D. Chen, H. Ping, N.J.I.j.o.b.s. Xing, Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K\/Akt signaling pathways, 16 (2020) 1121-1134.","DOI":"10.7150\/ijbs.41686"},{"key":"10.1016\/j.addr.2022.114445_b1305","doi-asserted-by":"crossref","unstructured":"T. Thangasamy, S. Sittadjody, G. Mitchell, E. Mendoza, V. Radhakrishnan, K. Limesand, R.J.B.c. Burd, Quercetin abrogates chemoresistance in melanoma cells by modulating deltaNp73, 10 (2010) 282.","DOI":"10.1186\/1471-2407-10-282"},{"key":"10.1016\/j.addr.2022.114445_b1310","doi-asserted-by":"crossref","unstructured":"Z. Gu, Q. Wang, Y. Shi, Y. Huang, J. Zhang, X. Zhang, G.J.J.o.c.r.o.j.o.t.C.R.S. Lin, Nanotechnology-mediated immunochemotherapy combined with docetaxel and PD-L1 antibody increase therapeutic effects and decrease systemic toxicity, 286 (2018) 369-380.","DOI":"10.1016\/j.jconrel.2018.08.011"},{"key":"10.1016\/j.addr.2022.114445_b1315","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3892\/ijmm.2016.2458","article-title":"Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: Analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells","volume":"37","author":"Hu","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.addr.2022.114445_b1320","doi-asserted-by":"crossref","first-page":"9703","DOI":"10.2147\/IJN.S274083","article-title":"Co-Delivery of Docetaxel and Curcumin via Nanomicelles for Enhancing Anti-Ovarian Cancer Treatment","volume":"15","author":"Hu","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.addr.2022.114445_b1325","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/nnano.2014.208","article-title":"Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy","volume":"9","author":"Chung","year":"2014","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.addr.2022.114445_b1330","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1021\/acsnano.9b00467","article-title":"Carrier-Enhanced Anticancer Efficacy of Sunitinib-Loaded Green Tea-Based Micellar Nanocomplex beyond Tumor-Targeted Delivery","volume":"13","author":"Yongvongsoontorn","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.addr.2022.114445_b1335","doi-asserted-by":"crossref","unstructured":"D. Wang, D. Yu, X. Liu, Q. Wang, X. Chen, X. Hu, Q. Wang, C. Jin, L. Wen, L. Zhang, Targeting laryngeal cancer cells with 5-fluorouracil and curcumin using mesoporous silica nanoparticles, Technol Cancer Res Treat, 19 (2020) 1533033820962114.","DOI":"10.1177\/1533033820962114"},{"key":"10.1016\/j.addr.2022.114445_b1340","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.colsurfb.2015.08.036","article-title":"Effects of doxorubicin mediated by gold nanoparticles and resveratrol in two human cervical tumor cell lines","volume":"135","author":"Tomoaia","year":"2015","journal-title":"Colloids Surf. B"},{"key":"10.1016\/j.addr.2022.114445_b1345","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2217\/nnm.15.183","article-title":"EGCG\/gelatin-doxorubicin gold nanoparticles enhance therapeutic efficacy of doxorubicin for prostate cancer treatment","volume":"11","author":"Tsai","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.addr.2022.114445_b1350","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00280-010-1470-2","article-title":"A phase I\/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer","volume":"68","author":"Kanai","year":"2011","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.addr.2022.114445_b1355","doi-asserted-by":"crossref","first-page":"8","DOI":"10.4161\/cbt.9.1.10392","article-title":"Phase I dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer","volume":"9","author":"Bayet-Robert","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.addr.2022.114445_b1360","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.phrs.2018.03.013","article-title":"Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial","volume":"132","author":"Pastorelli","year":"2018","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.addr.2022.114445_b1365","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.suronc.2017.07.002","article-title":"Beta-elemene treatment is associated with improved outcomes of patients with esophageal squamous cell carcinoma","volume":"26","author":"Chang","year":"2017","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.addr.2022.114445_b1370","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1016\/j.cclet.2021.03.049","article-title":"Combined nanosuspensions from two natural active ingredients for cancer therapy with reduced side effects","volume":"32","author":"Qiao","year":"2021","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.addr.2022.114445_b1375","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.cclet.2020.11.006","article-title":"The progress and perspective of strategies to improve tumor penetration of nanomedicines","volume":"32","author":"Hu","year":"2021","journal-title":"Chin. Chem. Lett."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X22003350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X22003350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T05:28:21Z","timestamp":1759210101000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X22003350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":275,"alternative-id":["S0169409X22003350"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2022.114445","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2022.114445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"114445"}}